Literature DB >> 8792427

Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.

K I Hosoya1, K J Kim, V H Lee.   

Abstract

PURPOSE: To determine whether the expression and activity of the P-glycoprotein (P-GP) drug efflux pump vary with the culture age of Caco-2 cell monolayers.
METHODS: Caco-2 cell monolayers were grown for 3-27 days on tissue culture-treated Transwells. P-GP efflux function was determined by measuring transmonolayer fluxes of cyclosporin A (CsA) and verapamil, while P-GP expression level was evaluated by Western blot analysis using monoclonal antibody C219.
RESULTS: The apparent permeability coefficient (Papp) of CsA (0.5 microM) in the basolateral-to-apical (B-->A) direction increased with culture age and was higher than the apical-to-basolateral (A-->B) direction at all times. Net secretory Papp significantly increased from day 17 onward compared to that observed during day 3 through 13. Verapamil (100 microM) significantly inhibited CsA transport in the B-->A direction from day 17 to 27, while elevating CsA transport in the A-->B direction from day 6 to 27. Interestingly, the Papp of verapamil (0.5 microM) in the B-->A direction was significantly higher than in the A-->B direction from day 6 to 27, rendering increases in net secretory Papp of verapamil with culture age. Western analysis revealed that P-GP expression level was in the order of 4 weeks approximately 1 week > 3 weeks > 2 weeks at equal loading of cell proteins.
CONCLUSIONS: P-GP is continuously expressed throughout the culture period, but it may not be fully functional at an early age. Caco-2 cell monolayers of day 17 to 27 appear to be a good model to evaluate the functional role of P-GP in drug efflux.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792427     DOI: 10.1023/a:1016005212640

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

Review 1.  P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.

Authors:  D Nielsen; T Skovsgaard
Journal:  Biochim Biophys Acta       Date:  1992-07-07

2.  Characterization of the unstirred water layer in Caco-2 cell monolayers using a novel diffusion apparatus.

Authors:  I J Hidalgo; K M Hillgren; G M Grass; R T Borchardt
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

3.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

4.  Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.

Authors:  P F Augustijns; T P Bradshaw; L S Gan; R W Hendren; D R Thakker
Journal:  Biochem Biophys Res Commun       Date:  1993-12-15       Impact factor: 3.575

5.  Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers.

Authors:  J Hunter; B H Hirst; N L Simmons
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

6.  Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2.

Authors:  H Saito; K Inui
Journal:  Am J Physiol       Date:  1993-08

7.  Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers.

Authors:  P Wils; V Phung-Ba; A Warnery; D Lechardeur; S Raeissi; I J Hidalgo; D Scherman
Journal:  Biochem Pharmacol       Date:  1994-10-07       Impact factor: 5.858

8.  Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine.

Authors:  H Saitoh; B J Aungst
Journal:  Pharm Res       Date:  1995-09       Impact factor: 4.200

9.  Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines.

Authors:  C Muller; J D Bailly; F Goubin; J Laredo; J P Jaffrézou; C Bordier; G Laurent
Journal:  Int J Cancer       Date:  1994-03-01       Impact factor: 7.396

10.  Common characteristics for Na+-dependent sugar transport in Caco-2 cells and human fetal colon.

Authors:  A Blais; P Bissonnette; A Berteloot
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

View more
  28 in total

1.  Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.

Authors:  Kazutoshi Horie; Fuxing Tang; Ronald T Borchardt
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

2.  Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features.

Authors:  K Suda; B Rothen-Rutishauser; M Günthert; H Wunderli-Allenspach
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

3.  Evaluation of the role of P-glycoprotein in ivermectin uptake by primary cultures of bovine brain microvessel endothelial cells.

Authors:  J M Rose; S L Peckham; J L Scism; K L Audus
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

4.  Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.

Authors:  L Yu; A Bridgers; J Polli; A Vickers; S Long; A Roy; R Winnike; M Coffin
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

5.  Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers.

Authors:  J Alsenz; H Steffen; R Alex
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

6.  Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells.

Authors:  E V Batrakova; H Y Han; D W Miller; A V Kabanov
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

7.  Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers.

Authors:  Y Zhang; L Z Benet
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

8.  Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.

Authors:  V D Makhey; A Guo; D A Norris; P Hu; J Yan; P J Sinko
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

9.  A modified coumarinic acid-based cyclic prodrug of an opioid peptide: its enzymatic and chemical stability and cell permeation characteristics.

Authors:  Hui Ouyang; Fuxing Tang; Teruna J Siahaan; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

10.  Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?

Authors:  Fuxing Tang; Kazutoshi Horie; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.